Alpine Immune Sciences raises $48 million for cancer and autoimmune treatment Seattle’s Alpine Immune Sciences says it has closed a $48 million Series A financing round, to fund the development of… Read More
Seattle’s Alpine Immune Sciences licenses cancer treatment to Kite Pharma for up to $530M Seattle-based immunotherapy startup Alpine Immune Sciences has signed an exclusive licensing deal with Kite Pharma that could be worth as… Read More
